Wolverine Trading’s Takeda Pharmaceutical TAK Stock Holding History

Wolverine Trading’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,100	Closed	-$175K	–	5685
2022 Q1	$175K	Buy	+12,100	New	+$178K	﹤0.01%	4508
2021 Q4	–	Sell	-26,700	Closed	-$435K	–	6808
2021 Q3	$435K	Sell	26,700 -26,700	-50%	-$448K	﹤0.01%	4139
2021 Q2	$899K	Sell	53,400 -134,900	-72%	-$2.3M	﹤0.01%	2904
2021 Q1	$3.46M	Buy	188,300 +142,600	+312%	+$2.57M	0.01%	1411
2020 Q4	$831K	Buy	45,700 +26,500	+138%	+$465K	﹤0.01%	2596
2020 Q3	$348K	Sell	19,200 -16,800	-47%	-$306K	﹤0.01%	3210
2020 Q2	$652K	Buy	36,000 +11,000	+44%	+$197K	﹤0.01%	2444
2020 Q1	$391K	Buy	+25,000	New	+$453K	﹤0.01%	2925
2019 Q3	–	Sell	-36,500	Closed	-$646K	–	4979
2019 Q2	$646K	Buy	36,500 +24,500	+204%	+$446K	﹤0.01%	2454
2019 Q1	$244K	Buy	+12,000	New	+$241K	﹤0.01%	3596

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Trading's TAK Position: Q4 2021 in Review

Wolverine Trading sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 10,376 shares — an estimated $169K sold.

Wolverine Trading first reported a position in TAK in Q4 2020 and held it in 4 quarters. The position peaked at $599K in Q4 2020. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Wolverine Trading reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 10,376 Takeda Pharmaceutical shares in Q4 2021, an estimated $169K.
Wolverine Trading first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 4 quarters.
Wolverine Trading's Takeda Pharmaceutical position peaked at $599K in Q4 2020.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.